Penumbra, Inc. (PEN – Free Report) , is an interventional therapies company that treats strokes with minimally invasive catheter technology. It has a $5 billion market cap. It recently announced that its Penumbra JET 7 and JET D Reperfusion Catheters would enable physicians to extract thrombus effectively and safely in acute ischemic stroke patients. Sales are expected to rise by double digits in 2018. Additionally, 2019 top-line estimates are currently looking for over 20% growth to a record $500 million, giving Penumbra a 10X price-to-sales ratio.
Microsoft(MSFT – Free Report) , is a multifaceted technology company. Microsoft has a dominant position in the desktop PC market, with its operating systems being used in the majority of PCs worldwide. The company is benefiting from growing user base of its different applications. Management execution has been good in recent times. This has helped Microsoft build cash and short term investments balance of $133.8 billion. The significant amount of cash provides the flexibility required to pursue any growth strategy, whether by way of acquisitions or otherwise.
Today’s Stocks from Zacks’ Hottest Strategies
It’s hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 – 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we’re willing to share their latest stocks with you without cost or obligation.